ARCHIVES

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

This article is from The Cancer Letter archive.

Vol. 37 No. 04 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Also NIH unveils Roadmap initiatives, releases four RFAs; Director Zerhouni defends peer review before House, Senate oversight committees, seeks greater authority for trans-NIH initiatives.

October 3, 2003

Can NCI Fund 4-Year Grants With 2-Year Stimulus Funds?

March 6, 2009

Community Assn. Plan Meeting In DC On Program Problems

November 29, 1974

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010